Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Obeticholic Acid on Gut Function in Healthy Volunteers
NCT05740631Phase 1Unknown
- Sponsor
- UZ Leuven
- Start
- Aug 2022
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in functional dyspepsia (FD) comparing Obeticholic acid with Placebo (2 arms). Primary endpoint: Changes in appetite. Status: unknown.
02
Drugs
obeticholic acid
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05740631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05740631.